Genesys Rights Committee to set issue price and ratio on July 31
Genesys International Corporation Limited has scheduled its Rights Issue Committee meeting for July 31, 2026, to fix the price, ratio, and record date for its ₹5 face value equity shares. This follows the Board's approval on June 26, 2026, and complies with SEBI Regulation 42 disclosure norms.
*this image is generated using AI for illustrative purposes only.
Genesys International Corporation Limited company name will finalize the key terms of its upcoming equity rights issue during a dedicated committee meeting scheduled for July 31, 2026. The Rights Issue Committee of the Board of Directors is set to decide on the issue price, the rights entitlement ratio, and the record date, marking the next procedural step after the Board’s initial approval in June. This decision is critical for eligible shareholders, as it will define their subscription rights and financial obligations for the capital raise.
The move follows a Board of Directors meeting held on June 26, 2026, where the company approved the rights issue of fully paid-up equity shares. Each share has a face value of ₹5. While the Board sanctioned the general framework of the issuance, specific commercial parameters were left to be determined by the specialized committee to ensure optimal market conditions and compliance with regulatory norms.
Key Agenda Items
The Rights Issue Committee’s agenda for the July 31 meeting focuses on establishing the definitive mechanics of the offer. The primary items for consideration include:
| Agenda Item | Description |
|---|---|
| Issue Price | Determining the monetary value at which new shares will be offered to existing shareholders. |
| Entitlement Ratio | Setting the ratio of new shares an existing shareholder can purchase relative to their current holding. |
| Record Date | Fixing the specific date by which shareholders must hold the stock to be eligible for the rights issue. |
| Other Modalities | Finalizing any additional procedural or administrative details related to the issuance. |
Regulatory Compliance and Next Steps
The company issued this prior intimation in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events to ensure transparency for investors and market participants. Genesys submitted the notice to both the BSE Limited and the National Stock Exchange of India Ltd. for dissemination on their respective websites.
The announcement was signed by Kushal Jain, Company Secretary & Compliance Officer, confirming the formal communication of the schedule. Once the committee concludes its deliberations on July 31, the company is expected to file further disclosures detailing the finalized terms, enabling eligible equity shareholders to prepare for the subscription process.
Historical Stock Returns for Genesys International Corp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.96% | -7.34% | -15.59% | +0.59% | -50.91% | +90.40% |
How might the finalized issue price and entitlement ratio impact Genesys International's stock price volatility in the weeks following the July 31 announcement?
What specific capital allocation strategies is Genesys likely pursuing with this equity raise, and how will they influence the company's future growth trajectory?
Could the timing of the record date create liquidity constraints for short-term traders, and how might this affect trading volumes on BSE and NSE?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
